When amplified direct (MTD) testing confuses leprosy diagnosis: A case report.
Schmitz S, Vatanchi M, Moussavi F, DeLury J, Heilman E. JAAD case reports. 2019; 5(2):131-133.
Risk factors for physical disability upon release from multidrug therapy in new cases of leprosy at a referral center in Brazil.
Assis B, Lyon S, de Grossi M, da Rocha M. Revista do Instituto de Medicina Tropical de Sao Paulo. 2019; 61e13.
Infections and reactions in leprosy: a diagnostic dilemma
Kaur J, Kalsy J, Kalra R. International journal of research in dermatology. 2018; 4(1):96-98.
Enriched whole genome sequencing identified compensatory mutations in the RNA polymerase gene of rifampicin-resistant Mycobacterium leprae strains.
Lavania M, Singh I, Turankar RP, Gupta A, Ahuja M, Pathak V, et al.. Infection and drug resistance. 2018; 11169-175.
A 19-year retrospective study of adverse drug reactions to multidrug therapy in leprosy requiring a change in regime.
Nair S. Indian dermatology online journal. 2018; 9(1):33-36.
Ribonucleotide reductase as a drug target against drug resistance Mycobacterium leprae: A molecular docking study.
Mohanty P, Bansal A, Naaz F, Gupta U, Dwivedi V, Yadava U. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2018; 6058-65.
Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India.
Singh S, Kumar A, Nath G, Singh T, Mishra M. Indian journal of dermatology, venereology and leprology. 2018;
Clinical and histopathological response to Multidrug therapy in paucibacillary leprosy at the end of 6 months: A prospective observational study from Eastern India.
Podder I, Saha A, Bandyopadhyay D. Indian journal of dermatology. 2018; 63(1):47-52.
Mycobacterium leprae- specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multi-drug therapy (MDT) or the uniform 6 doses MDT.
Hungria EM, Bührer-Sékula S, Oliveira RM, Aderaldo LC, Pontes MA, Cruz R, et al.. Frontiers in immunology. 2018;
Specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multidrug therapy (MDT) or the uniform 6 doses MDT.
Hungria EM, Bührer-Sékula S, Oliveira RM, Aderaldo LC, Pontes M, Cruz R, et al.. Frontiers in immunology. 2018; 9915.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.